REGENCELL BIOSCIENCE HOLDINGS LIMITED

Highlights Regencell Bioscience Holdings Limited

Equities

RGC

KYG7487R1002

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-09 pm EDT			5-day change	1st Jan Change
5.56 ^USD	-10.61%		+4.32%	-47.05%

2023	Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI
2023	Regencell Bioscience Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-27	CI
Regencell Bioscience Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-06-15	CI
Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-10-31	CI
Regencell Bioscience Holdings Limited Announces its Standardized Formulae Shows Reduce ADHD and ASD Symptoms in Interim Results of its Second Efficacy Trial	22-09-12	CI
Regencell Bioscience : Announces First Half 2022 Management Financial Results - Form 6-K	22-06-02	PU
Regencell Bioscience Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-06-02	CI
Regencell Bioscience Holdings Limited Announces Additional Earth Efficacy Trial Results Corroborating Effectiveness of Its Investigational Liquid-Formula Rgc-Cov19tm in Eliminating Mild to Moderate Covid-19 Symptoms Within the 6-Day Treatment Period	22-05-18	CI
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO	22-05-16	BU
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO	22-05-16	BU
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19 Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial	22-02-16	CI
Certain Warrants of Regencell Bioscience Holdings Limited are subject to a Lock-Up Agreement Ending on 12-JAN-2022.	22-01-11	CI
Certain Ordinary Shares of Regencell Bioscience Holdings Limited are subject to a Lock-Up Agreement Ending on 12-JAN-2022.	22-01-11	CI
Regencell Bioscience : Forms Joint Venture to Offer COVID-19 Treatment to Select Asia Pacific Countries	21-09-02	MT
Update: Regencell Bioscience Raises $24.9 Million from IPO -- Shares More Than Triple Amid Heavy Trading Volume	21-08-20	MT
Regencell Bioscience : Says IPO Raised $24.9 Million	21-08-20	MT
Regencell Bioscience Holdings Limited : Announces Closing of Initial Public Offering	21-07-20	BU
Regencell Bioscience : Hong Kong's Regencell Bioscience Rises in Nasdaq Debut	21-07-16	MT
Regencell Bioscience Holdings Limited has completed an IPO in the amount of $21.85 million.	21-07-15	CI
Regencell Bioscience Holdings Limited has filed an IPO in the amount of $17.724375 million.	21-03-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Stock Market
Equities
RGC Stock
News Regencell Bioscience Holdings Limited
Highlights

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW